Dr. Jaclyn Beth Gurwin, MD

Dr. Gurwin practices at Delaware Valley Vision Associates Group Practice in King Of Prussia, Pennsylvania.

Dr. Gurwin's NPI, 1194107649, was assigned on June 22, 2015. Dr. Gurwin holds Pennsylvania license MD473326.

Dr. Gurwin's primary practice is Delaware Valley Vision Associates Group Practice, at 1018 W 9th Ave, King Of Prussia, PA 19406 in Montgomery County. The practice phone is (610) 337-1580.

Dr. Gurwin's primary practice is Delaware Valley Vision Associates Group Practice in King Of Prussia, Pennsylvania. Dmand AI also links Dr. Gurwin to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gurwin practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Gurwin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Gurwin's licenses on file in 2 states: Pennsylvania and Wisconsin.

CMS data shows 613 Medicare services from Dr. Gurwin across 11 procedure codes in 2024, for 335 Medicare patients. Medicare paid $79,734 for them.

CMS counts 335 Medicare patients who saw Dr. Gurwin in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gurwin's median patient age at 62, with 64% women.

In 2024, Dr. Gurwin wrote 423 Medicare Part D claims for 241 patients. 47% of them were for generic drugs. CMS names the drug for 386 of them, across 4 drugs with 11 or more claims each, at $5,111 in total drug cost. In 2023, CMS named 212 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Gurwin for performance year 2024, reported as part of a group. Dr. Gurwin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of melanoma (skin cancer) excision by Dr. Gurwin, more than 70% of the clinicians it reports for that procedure.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Gurwin, published from 2017 to 2023. Dr. Gurwin's most frequent co-authors are Gil Binenbaum, MD, Katherine Dalzotto, MD and Stephanie M. Davidson, MD.

CMS Open Payments shows 41 general payments to Dr. Gurwin from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Alcon Laboratories Inc paid the most, $452.